Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 11
197
Views
6
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Evaluating the enantioselective distribution, degradation and excretion of epoxiconazole in mice following a single oral gavage

, , , , , , & show all
Pages 1009-1015 | Received 03 Feb 2015, Accepted 22 Mar 2015, Published online: 25 Jun 2015
 

Abstract

1. The enantiomeric enrichment or degradation of epoxiconazole has been reported in grape, soil, tubifex and mealworm beetle. But, little is known about its enantioselective behaviors in mammals.

2. To further understand differences in the distribution, degradation and excretion of epoxiconazole enantiomers in vivo, male CD-1 mice were selected as the test model to investigate the enantioselective behaviors after a single oral gavage. Mice were sacrificed after 1 h, 3 h, 7 h, 12 h, 24 h, 48 h, 72 h treatment, blood, tissues and excretions were collected for epoxiconazole analysis by LC-MS/MS.

3. On the Lux-Cellulose-1 chiral column, an enrichment of the second eluting (+)-epoxiconazole was generally observed, and feces and urine showed similar EF with major tissues.

4. To elucidate the potential role of intestinal bacterial flora in stereospecific degradation of epoxiconazole, mice fecal flora were cultured in vitro and incubated with epoxiconazole for 48 h. Results showed that (−)-epoxiconazole was preferentially degraded by intestinal bacterial.

5. These results may provide useful information for risk assessment of epoxiconazole on non-target animals.

Declaration of interest

The authors report no declarations of interest. We gratefully acknowledge financial support of National Natural Science Foundation of China (21207158, 21337005) and Chinese Universities Scientific Fund (2012RC026).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.